Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Capital Expenditures (2016 - 2025)

Sanara MedTech's Capital Expenditures history spans 11 years, with the latest figure at $82159.0 for Q4 2025.

For Q4 2025, Capital Expenditures rose 13.84% year-over-year to $82159.0; the TTM value through Dec 2025 reached $4.6 million, up 2147.12%, while the annual FY2025 figure was $4.6 million, 2147.12% up from the prior year.
Capital Expenditures reached $82159.0 in Q4 2025 per SMTI's latest filing, down from $1.1 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $1.8 million in Q2 2025 to a low of $4391.0 in Q1 2021.
Average Capital Expenditures over 5 years is $270781.3, with a median of $53820.0 recorded in 2022.
Peak YoY movement for Capital Expenditures: tumbled 94.66% in 2024, then surged 11547.79% in 2025.
A 5-year view of Capital Expenditures shows it stood at $141710.0 in 2021, then plummeted by 62.34% to $53364.0 in 2022, then grew by 1.71% to $54276.0 in 2023, then skyrocketed by 32.97% to $72172.0 in 2024, then grew by 13.84% to $82159.0 in 2025.
Per Business Quant, the three most recent readings for SMTI's Capital Expenditures are $82159.0 (Q4 2025), $1.1 million (Q3 2025), and $1.8 million (Q2 2025).